NVLG: Revenue up, net income surged, but SAP rollout caused one-time costs and legal exposure

About this update from Novolog (pharm Up 1966) Ltd.

Revenue and net income rose year-over-year, but logistics faced one-time SAP rollout costs and a class action risk. Adjusted EBITDA declined, and management is focused on efficiency and digital investments.Original document: This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.

View stock analysis, news, and events for Novolog (pharm Up 1966) Ltd.